News
The invisible infrastructure of patient safety and why digital governance matters

By Misbah Mahmood, CXIO & Clinical Safety Officer, Bradford District Care Trust, (Former digital midwife at Leeds Teaching Hospitals and long-standing K2/HHA customer and collaborator)
Across the NHS, digital governance is frequently misunderstood.
It is often seen as a bureaucratic necessity or a technical, administrative process that becomes invisible once a system goes live or as a barrier to innovation when services are under pressure to change quickly.
However, digital systems do far more than document care. They shape how care is delivered, how risk is identified and interpreted, and how clinical decisions are made.
When systems are well designed and well governed, they support clinical judgement and safe practice.
When they are not, the impact is felt directly at the bedside, as illustrated by recent concerns over an AI discharge summary tool trialled at Chelsea and Westminster.
Here, unresolved questions about regulatory status and assurance exposed the consequences of deploying clinically influential technology without sufficient clarity or oversight.
In maternity services in particular, care is complex, unpredictable, and deeply dependent on context. Rapid decision making and information continuity across settings are essential.
As digital systems increasingly influence day-to-day practice, the way they are designed, governed, and used can either reinforce safe care or quietly undermine it.
Digital governance distinguishes technology that protects women and babies from technology that introduces hidden risk.
The myth of “invisible infrastructure”
When people hear the word “governance”, they often think of forms, meetings and compliance. For clinicians, it can feel like a tick box exercise that sits in the way of getting things done.
But governance decisions show up at the most critical moments of care, often without being named as such.
As clinicians, we instinctively understand safety in physical terms. If a blood pressure machine stops working, that’s immediately recognised as a patient safety issue. It gets escalated, reported and fixed.
But for a long time, digital issues have not been treated the same way. Slow systems, unreliable access, or inability to view the EPR were often accepted as “just one of those things”. Yet the impact on safety can be just as significant.
If you can’t see the record, you can’t see the risks. If you can’t trust the system, you start working around it.
Electronic patient records are no longer passive repositories of information. They influence what clinicians notice, how quickly they escalate concerns and what decisions they make.
That means the way these systems are governed, and how they are designed, tested and introduced, has direct consequences for patient safety.
A good example of this is central foetal monitoring. Used well, it can support situational awareness. But without clear governance and shared understanding, it can also create a false sense of security.
Being explicit that central monitoring does not replace bedside assessment or escalation is essential. If staff assume “someone else is watching”, the technology has unintentionally weakened safety.
Why safe digital infrastructure matters more than ever in maternity
Maternity care is non‑linear. Risk changes rapidly, and plans change, as women move between community and hospital settings.
Many digital systems are built around rigid templates and linear workflows that do not reflect this reality. When systems don’t fit practice, practice adapts.
Parallel notes, paper diaries, and reliance on free text are not resistance to digital tools; they are practical responses to keep care safe.
Operational realities add further challenge. Community midwives work across geography with unreliable connectivity, making offline access a safety requirement rather than a technical convenience.
Systems that support secure offline working reduce rushed documentation and missed safety checks.

Misbah Mahmood
On the labour ward, pressures intensify. Emergencies escalate quickly and staff are often fatigued. Here, usability becomes inseparable from safety.
Systems that add unnecessary steps increase cognitive load precisely when attention must remain on the patient. At four in the morning, design can either support safe decision‑making or work against it.
When the safest decision is saying “not now”
Digital governance is as much about preventing unsafe change as enabling innovation. Not every system that is technically ready is clinically ready.
Introducing change during periods of strain, limited training, or inadequate testing increases risk.
Pausing a rollout is rarely comfortable as delivery pressures create momentum to proceed. Effective governance, however, gives organisations permission to prioritise safety over speed.
Delaying implementation to allow further testing or clinical engagement often leads to safer adoption and greater staff trust.
Saying “not now” is not resistance to change. It is a mature safety response, as introducing change at the wrong time can cause harm that is far harder to undo.
Co‑design, not configuration: new models for supplier partnerships
Safe digital transformation depends on genuine partnership between NHS teams and suppliers, with shared responsibility for clinical risk.
Effective collaboration starts early, with meaningful clinical involvement, transparency about system constraints, and shared understanding of risk.
It continues through testing in real clinical environments and shared accountability for safety outcomes after go‑live.
Working with Harris Health Alliance and the K2 maternity tool made these conversations more effective.
Responsiveness to safety feedback was faster, and small design changes, such as surfacing critical risk information or adding validation checks to reduce error under fatigue, had significant impact on usability and safety.
Every change, however minor it appears, is a clinical safety decision. Digital governance provides the structure to recognise this and ensure changes are designed and implemented accordingly.
People, process and technology are an interdependent system
Technology does not fail in isolation. Risk emerges when people, processes, and digital systems are misaligned. Even the most sophisticated EPR will struggle if staff are unsupported, processes have not evolved, or workflows do not reflect clinical reality.
Technology can also obscure risk by embedding unsafe or outdated practices into systems that appear efficient when governance focuses only on technical delivery.
Effective digital governance recognises that patient safety depends on the interaction between people, processes, and technology.
Skills, confidence, and behaviours matter, as do evidence‑based, consistent processes and systems that are usable, reliable, and aligned with real clinical work.
Safety improves when these elements are deliberately aligned and governance focuses on learning rather than blame.
Design matters and systems must be fast, predictable, and forgiving of human fatigue. The same principle is evident in data quality.
A yes/no field relating to cord prolapse produced alarming figures due to human factors rather than practice.
Introducing a simple validation check prompting confirmation improved data quality and reduced risk by addressing system design, not individual behaviour.
This is digital governance in practice. It is recognising where design and reality collide and fixing the system rather than blaming clinicians.
From invisible to essential
Digital governance should no longer be invisible. It must be recognised, valued, and treated as a core component of patient safety.
That means involving clinical safety expertise from the outset, listening to frontline concerns, designing for real-world conditions, and being willing to pause when something does not feel safe.
The absence of incidents does not mean the absence of risk; often, it means the system has not yet failed under the wrong circumstances.
Maternity services, with their complexity and sensitivity, have much to teach the wider NHS about safe digital transformation.
When governance is shared, practical, and grounded in real clinical experience, digital systems can genuinely support safer care and not just record it.
Menopause
Apple Health adds menopause and perimenopause tracking

Apple announced menopause and perimenopause tracking for its Health app at WWDC 2026, with symptom logging and cycle alerts for some users.
The update expands the app’s cycle tracking beyond fertility and menstrual periods.
If logged cycle patterns suggest a user may be experiencing perimenopause, the app will send a notification prompting a conversation with a doctor.
However, this perimenopause-specific cycle deviation notification is only for users aged 40 and over and is not intended to replace a doctor’s diagnosis or treatment.
Stacey Ford, Apple’s vice-president of OS management, said users will also be able to log menopause and perimenopause symptoms in the Health app.
Educational content will also be available to help users learn more about these life stages and understand changes in their bodies.
Every year, about 2 million women enter perimenopause, the stage before menopause when levels of the hormone oestrogen decline.
According to a February 2025 survey involving 4,432 participants aged over 30, more than half of women aged 30 to 35 experienced moderate or severe perimenopause symptoms.
The findings suggest perimenopause does not affect only older adults.
About 6,000 women in the US enter menopause every day, according to the Society for Women’s Health Research.
Given the number of women affected by perimenopause and menopause, the update broadens the Health app’s scope.
The app launched in 2019, meaning it has gone seven years without these women’s health tracking features, which could help users better understand their bodies and prepare for informed conversations with doctors.
Pregnancy
£50m initiative aims to tackle disparities in maternal healthcare
Insight
Peers call on UK government to review fertility and surrogacy laws

Peers have called for law reform after two House of Lords debates on fertility treatment, surrogacy, embryo research and declining birthrates.
The first debate was put forward by crossbench peer Baroness Ruth Deech, who previously chaired the UK’s fertility regulator, the Human Fertilisation and Embryology Authority.
She discussed proposals from the HFEA to reform the Human Fertilisation and Embryology Act, along with proposals from the Scottish Law Commission and the Law Commission of England and Wales to reform the Surrogacy Arrangements Act.
She called for parliamentary scrutiny of possible changes to regulatory powers, consent rules, donor information and future scientific developments.
Baroness Deech said: “Parliament should plan by setting up a Select Committee to examine the HFEA’s proposals to expand regulatory powers, simplify consent rules, modernise donor information provisions and create a flexible framework for future scientific developments.”
Former fertility professionals were among those contributing to the debate.
Professor Lord Robert Winston, a Labour peer who founded the IVF service at Hammersmith Hospital in London, said: “Infertility is not a disease; it is actually a symptom of something wrong.”
Professor Baroness Geeta Nargund, a Labour peer, current HFEA member and former medical director of CREATE Fertility, disagreed.
She said: “Infertility is a disease, as stated by the World Health Organisation.”
Liberal Democrat peer Baroness Caroline Pidgeon highlighted regional differences in access to NHS-funded fertility treatment.
She cited figures from the Progress Educational Trust’s NHS Fertility Funding Tracker showing that only two of England’s 42 integrated care boards comply with the recently updated fertility guideline published by the National Institute for Health and Care Excellence.
Integrated care boards are local NHS organisations responsible for planning and funding healthcare services in their areas.
Baroness Pidgeon said many boards were offering only a partial IVF cycle rather than a full cycle as defined by NICE.
A full IVF cycle generally includes ovarian stimulation, egg collection and the transfer of all suitable fresh and frozen embryos created during treatment.
Crossbench peer Professor Baroness Clare Gerada, a former president of the Royal College of General Practitioners, said: “The proportion of NHS-funded IVF cycles has fallen to just under 30 per cent, the lowest level since 2008.”
She added that, in relation to IVF, “the NHS system has collapsed”.
Liberal Democrat peer Lord Monroe Palmer said it was “very ironic that it is difficult for many patients to access publicly funded fertility treatment in the very country where IVF was originally pioneered”.
Conservative peer Edward Howard, Earl of Effingham, also raised concerns about the NICE fertility guideline.
He said: “Access remains highly variable across England, because ICBs are not required to implement that guidance.”
He described the situation as “a clear gap between guidance and enforceable entitlement”.
Baroness Deech called for “automatic record sharing between clinics and the NHS central records system”.
Baroness Nargund supported this and linked the ambition to the Single Patient Record in the government’s Ten-Year Health Plan for England and the Health Bill currently before Parliament.
Baroness Pidgeon said such ambitions were at odds with the exceptional degree of medical secrecy that currently applies to IVF.
She also pointed to “a clear desire for the HFEA to be able to permit patients to give generic consent for the use of their embryos in research”.
Patients cannot currently give broad consent for unspecified future research involving their embryos.
Responding for the government, Labour peer Baroness Judith Blake said “immediate legislative reform” was not possible because “the legislative programme for this Parliamentary session is very full”.
Baroness Deech replied: “It might well take some years, but the Government really needs to set up that Select Committee and do the legislative scrutiny right now.”
A second debate on related issues followed immediately afterwards.
Baroness Nargund asked the government “what assessment they have made of the UK’s declining birthrates in an ageing population”.
She also said: “We still have a postcode lottery for IVF provision, with nearly 70 per cent of ICBs funding only one cycle of treatment.”
Responding for the government, Labour peer Lord Philip Wilson said: “The Government are committed to improving fair and equitable access to fertility services, recognising the significant emotional and health impacts of infertility.”
Menopause2 weeks agoPerimenopause misinformation ‘putting women at risk’
Hormonal health3 weeks agoNHS urged to update website following renaming of PCOS
Insight4 weeks agoPCOS renamed after decade-long campaign to end ‘cyst’ misconception
Menopause2 weeks agoWomen still being failed when they reach menopause, experts say
Entrepreneur2 weeks agoWomen’s Health Innovation Summit opens submissions for 2026 Innovation Showcase
Diagnosis4 weeks agoArtera receives FDA Clearance for breast cancer platform
Fertility4 weeks agoAI could transform ovarian care through personalisation, study finds
News2 weeks agoThree menopause innovators shortlisted for Femtech World Award









